135 related articles for article (PubMed ID: 20851882)
1. The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.
Adapala NS; Barbe MF; Langdon WY; Nakamura MC; Tsygankov AY; Sanjay A
J Biol Chem; 2010 Nov; 285(47):36745-58. PubMed ID: 20851882
[TBL] [Abstract][Full Text] [Related]
2. F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways.
Zhang Y; Wang H; Zhu G; Qian A; Chen W
Int J Biol Sci; 2020; 16(9):1629-1639. PubMed ID: 32226307
[TBL] [Abstract][Full Text] [Related]
3. Intracellular and extracellular ATP coordinately regulate the inverse correlation between osteoclast survival and bone resorption.
Miyazaki T; Iwasawa M; Nakashima T; Mori S; Shigemoto K; Nakamura H; Katagiri H; Takayanagi H; Tanaka S
J Biol Chem; 2012 Nov; 287(45):37808-23. PubMed ID: 22988253
[TBL] [Abstract][Full Text] [Related]
4. Morusin inhibits breast cancer-induced osteolysis by decreasing phosphatidylinositol 3-kinase (PI3K)-mTOR signalling.
Zhang L; Li W; Chen X; Cao D; You S; Shi F; Luo Z; Li H; Zeng X; Song Y; Li N; Akimoto Y; Rui G; Chen Y; Wu Z; Xu R
Chem Biol Interact; 2024 May; 394():110968. PubMed ID: 38522564
[TBL] [Abstract][Full Text] [Related]
5. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.
Whyte LS; Ryberg E; Sims NA; Ridge SA; Mackie K; Greasley PJ; Ross RA; Rogers MJ
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16511-6. PubMed ID: 19805329
[TBL] [Abstract][Full Text] [Related]
6. Targeting phosphatidylinositol-3-kinase for inhibiting maxillary bone resorption.
Santos MS; Lima VTM; Barrioni BR; Vago JP; de Arruda JAA; Prazeres PD; Amaral FA; Silva TA; Macari S
J Cell Physiol; 2023 Nov; 238(11):2651-2667. PubMed ID: 37814842
[TBL] [Abstract][Full Text] [Related]
7. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption.
McDonald MM; Khoo WH; Ng PY; Xiao Y; Zamerli J; Thatcher P; Kyaw W; Pathmanandavel K; Grootveld AK; Moran I; Butt D; Nguyen A; Corr A; Warren S; Biro M; Butterfield NC; Guilfoyle SE; Komla-Ebri D; Dack MRG; Dewhurst HF; Logan JG; Li Y; Mohanty ST; Byrne N; Terry RL; Simic MK; Chai R; Quinn JMW; Youlten SE; Pettitt JA; Abi-Hanna D; Jain R; Weninger W; Lundberg M; Sun S; Ebetino FH; Timpson P; Lee WM; Baldock PA; Rogers MJ; Brink R; Williams GR; Bassett JHD; Kemp JP; Pavlos NJ; Croucher PI; Phan TG
Cell; 2021 Mar; 184(5):1330-1347.e13. PubMed ID: 33636130
[TBL] [Abstract][Full Text] [Related]
8. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer.
Qian J; Gong ZC; Zhang YN; Wu HH; Zhao J; Wang LT; Ye LJ; Liu D; Wang W; Kang X; Sheng J; Xu W; Liu XL; Wu J; Zheng W
Cell Commun Signal; 2021 Jan; 19(1):9. PubMed ID: 33478523
[TBL] [Abstract][Full Text] [Related]
9. FTO regulates osteoclast development by modulating the proliferation and apoptosis of osteoclast precursors in inflammatory conditions.
He J; Zhao Y; Zhang Y; Zhang Z; Li D; Xu Q
Cell Signal; 2024 May; 117():111098. PubMed ID: 38365111
[TBL] [Abstract][Full Text] [Related]
10. Regulation of osteoclast-mediated bone resorption by microRNA.
Ji L; Li X; He S; Chen S
Cell Mol Life Sci; 2022 May; 79(6):287. PubMed ID: 35536437
[TBL] [Abstract][Full Text] [Related]
11. Pulling rank with RNA: RANKL promotes the association of PGC-1β/RNA complexes with NCoR/HDAC3 to activate gene expression in osteoclasts.
Torres HM; Yeo D; Westendorf JJ
Mol Cell; 2023 Oct; 83(19):3397-3399. PubMed ID: 37802020
[TBL] [Abstract][Full Text] [Related]
12. The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration.
Munugalavadla V; Vemula S; Sims EC; Krishnan S; Chen S; Yan J; Li H; Niziolek PJ; Takemoto C; Robling AG; Yang FC; Kapur R
Mol Cell Biol; 2008 Dec; 28(23):7182-98. PubMed ID: 18809581
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cytoplasmic adaptor protein Hem1 promotes osteoclast fusion and bone resorption in mice.
Wang X; Shao L; Richardson KK; Ling W; Warren A; Krager K; Aykin-Burns N; Hromas R; Zhou D; Almeida M; Kim HN
J Biol Chem; 2023 Feb; 299(2):102841. PubMed ID: 36574841
[TBL] [Abstract][Full Text] [Related]
14. Type I phosphotidylinosotol 4-phosphate 5-kinase γ regulates osteoclasts in a bifunctional manner.
Zhu T; Chappel JC; Hsu FF; Turk J; Aurora R; Hyrc K; De Camilli P; Broekelmann TJ; Mecham RP; Teitelbaum SL; Zou W
J Biol Chem; 2013 Feb; 288(8):5268-77. PubMed ID: 23300084
[TBL] [Abstract][Full Text] [Related]
15. New Horizons: Translational Aspects of Osteomorphs.
Park-Min KH; Mun SH; Bockman R; McDonald MM
J Clin Endocrinol Metab; 2024 Apr; 109(5):e1373-e1378. PubMed ID: 38060842
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment.
Liyasova MS; Ma K; Lipkowitz S
Clin Cancer Res; 2015 Apr; 21(8):1789-94. PubMed ID: 25477533
[TBL] [Abstract][Full Text] [Related]
17. Modulation of bone resorption by phosphorylation state of bone sialoprotein.
Curtin P; McHugh KP; Zhou HY; Flückiger R; Goldhaber P; Oppenheim FG; Salih E
Biochemistry; 2009 Jul; 48(29):6876-86. PubMed ID: 19518132
[TBL] [Abstract][Full Text] [Related]
18. Development of an optogenetics tool, Opto-RANK, for control of osteoclast differentiation using blue light.
Takada A; Asano T; Nakahama KI; Ono T; Nakata T; Ishii T
Sci Rep; 2024 Jan; 14(1):1749. PubMed ID: 38242937
[TBL] [Abstract][Full Text] [Related]
19. Cortactin controls bone homeostasis through regulating the differentiation of osteoblasts and osteoclasts.
Yang X; Chen M; Wang S; Hu X; Zhou J; Yuan H; Zhu E; Wang B
Stem Cells; 2024 Apr; ():. PubMed ID: 38655781
[TBL] [Abstract][Full Text] [Related]
20. L-arginine inhibits arthritis and bone loss by reprogramming osteoclast metabolism.
Onuora S
Nat Rev Rheumatol; 2023 Dec; 19(12):760. PubMed ID: 37919338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
